Table 6.
Main laboratory data in general study population.
| n=231 | Mean | SD | Med | 25 | 75 | P |
| CRP 0 | 142.3 | 69.0 | 129.2 | 95 | 201.3 | p 0.085 |
| CRP 2 | 157.3 | 79.0 | 158.0 | 102.2 | 250 | |
| CRP 4 | 129.1 | 105.7 | 133.8 | 19.1 | 249.7 | |
| PCT 0 | 0.57 | 0.83 | 0.30 | 0.15 | 0.62 | p 0.005 |
| PCT 2 | 1.28 | 14.1 | 0.63 | 0.26 | 1.48 | |
| PCT 4 | 0.96 | 1.25 | 0.49 | 0.16 | 1.15 | |
| Glyc 0 | 150 | 71 | 126 | 108 | 163 | p 0.844 |
| Glyc 2 | 153 | 57 | 137 | 116 | 178 | |
| Glyc 4 | 159 | 65 | 144 | 113 | 196 | |
| D-d 0 | 1829 | 2539 | 823 | 606 | 1236 | p 0.002 |
| D-d 2 | 4371 | 3646 | 2052 | 1157 | 9000 | |
| D-d 4 | 5774 | 3442 | 6866 | 1699 | 9000 |
n, number; SD, standard deviation Med, median; 25, 25th percentile; 75, 75th percentile; CRP, C reactive protein (mg/l); PCT, procalcitonin (ng/ml): (0 vs 2 – p=0.003; 0 vs 4 – p= 0.643; 4 vs 2 – p=0.011); Glyc, glycemia (mg/dl); D-d, D-dimer (µg/ml): (0 vs 2 – p=0.029 0 vs 4 – p=0.001 4 vs 2 – p=0.195); 0, Hospital admission; 2, NIV start; 4, NIV suspension.